The global goal of getting 15 million people on life-saving antiretroviral (ARV) treatment has been met nine months early, the Joint United Nations Programme on AIDS (UNAIDS) announced today.
With more than one in 10 health facilities nationally reporting a drug stock out in the last nine months, this year’s SA AIDS Conference may have been more about what’s missing than what’s been done in the country’s HIV programme.
With 3.1 million people on antiretrovirals (ARV), South Africa has the world’s largest ARV programme, but sustaining it – and the HIV response – will more than double in the next two decades, according to new research.
Health Minister Dr Aaron Motsoaledi has blamed manufacturers for shortages of medicines including HIV and tuberculosis drugs, but a civil society coalition has alleged 80 percent of stock outs are due to poor management.
In 2002, only 25,000 HIV-positive South Africans had access to exorbitantly life-saving antiretrovirals (ARVs) costing thousands of rands. Today, the story is much different and a new book chronicles one of its most important chapters.
February marked the one-year anniversary of her brother’s death due to AIDS-related illnesses, but Sazi Mnyageni says she keeps her brother’s memory alive every time she counsels a person on HIV.